Skip to content
★ Sign in to follow
에이

에이치엘비사이언스 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by HLB생명과학, was filed 13 Dec 2024.

에이치엘비사이언스: what insiders have been doing

에이치엘비사이언스 is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 10 November 2025 to 10 November 2026, the disclosure feed for 에이치엘비사이언스 logged 2 filings by 2 insiders.

No insider bought on the market over the period, while 2 insiders filed 2 sales. The totals exclude 2 filings filed without an amount.

For context, the typical company on the same exchange (median of 2,648 companies) published 7 filings over the same period, against 2 filings here. The full history, which starts in 2021, counts 8 purchases against 15 sales.

Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
39
Thresholds
n/a
Buy Volume
n/a
8 ops. · all time
Sell Volume
n/a
15 ops. · all time

Who traded when

BuySale
Hlb글로벌1 sale
Hlb생명과학1 buy
Yoon Jong Sun1 sale

Financial data

· cache

Last declaration on 8 January 2026
Declarations39 total
  • ▼
    Executives
    0DART
    11,969,845 sharesKRXDART:20260108000599
  • ▼
    Executives(filed)
    0DART
    120,000 sharesShareKRXDART:20260106000305
  • ▲
    -Executives(filed)
    0DART
    1,393,404 sharesShareKRXDART:20241213000558
    Canonical exit: 13 Mar 2025 (T+90)
  • ▲
    -Executives(filed)
    0DART
    161,639 sharesShareKRXDART:20241112000333
    Canonical exit: 10 Feb 2025 (T+90)
  • ▲
    Executives
    0DART
    1,322,554 sharesKRXDART:20241016000064
    Canonical exit: 8 Jan 2025 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20240813001143
    Canonical exit: 7 Nov 2024 (T+90)
  • ▲
    Executives
    0DART
    838,897 sharesKRXDART:20240613000001
    Canonical exit: 2 Sept 2024 (T+90)
  • ▼
    Executives
    0DART
    929,739 sharesKRXDART:20240610000263
  • ▲
    Executives
    0DART
    335,164 sharesShareKRXDART:20240216001004
    Canonical exit: 9 May 2024 (T+90)
  • ●
    -Executives
    0DART
    ShareKRXDART:20231110000489
  • ▼
    Executives
    0DART
    929,739 sharesKRXDART:20231006000500
  • ●
    -Executives
    0DART
    ShareKRXDART:20231006000123
  • ●
    -Executives
    0DART
    ShareKRXDART:20230817000303
  • ●
    -Executives
    0DART
    ShareKRXDART:20230619000047
  • ▼
    Executives
    0DART
    929,739 sharesKRXDART:20230619000071
  • ●
    -Executives
    0DART
    ShareKRXDART:20230519000578
  • ●
    -Executives
    0DART
    ShareKRXDART:20230519000581
  • ●
    -Executives
    0DART
    ShareKRXDART:20230519000584
  • ▼
    Executives
    0DART
    929,739 sharesKRXDART:20230519000592
  • ●
    -Executives
    0DART
    ShareKRXDART:20230512001047
  • ▼
    Executives(filed)
    0DART
    929,739 sharesKRXDART:20230324000981
  • ▲
    Executives
    0DART
    5,906,928 sharesShareKRXDART:20230214000806
    Canonical exit: 23 Jul 2020 (T+90)
  • ▲
    Executives
    0DART
    2,087,126 sharesShareKRXDART:20230214000862
    Canonical exit: 10 May 2023 (T+90)
  • ▼
    Executives(filed)
    0DART
    929,739 sharesKRXDART:20230214000792
  • ▼
    Executives(filed)
    0DART
    929,739 sharesKRXDART:20221229000760

25 of 39 declarations

About 에이치엘비사이언스

HLB Science is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative treatments for various diseases.